• About
  • Team
  • Contact
  • Editorial Standards
  • Core Values
  • Terms of Service
  • Privacy Policy
  • Affiliate Disclosure
Resist the Mainstream
No Result
View All Result
STORE
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
NEWSLETTER
Get Ad-Free Login Manage Account
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
No Result
View All Result
Resist the Mainstream
No Result
View All Result

FDA Issues Alert, Announces Recall of Common Thyroid Medication

Tony Gray by Tony Gray
February 3, 2023
1
FDA Issues Alert, Announces Recall of Common Thyroid Medication

RELATED

Video: Girl Straddled by Drag Queen Sparks Outrage at North Carolina School

Watch: Candace Owens Spars With Professor on Affirmative Action in Feisty ‘Dr. Phil’ Appearance: ‘I’m Giving You Actual Facts’

A pharmaceutical manufacturer voluntarily recalled a common thyroid medication because some doses were found to be subpotent.

ADVERTISEMENTS
ON
OFF

IBSA issued a recall notice for 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level, according to the U.S. Food and Drug Administration. The drug is used to treat hypothyroidism (underactive thyroid).

Advertisements

Thyroid hormones control the rate at which a person burns calories and how fast the heart beats, according to a WebMD report. Underactive thyroid glands produce too little thyroid hormone to control those activities.

“The company’s analyses show a slight decrease below 95.0% of its labeled amount in levothyroxine sodium (T4) for some lots,” a IBSA statement explained.

Patients with underactive thyroid treated with subpotent TIROSINT®-SOL, may experience symptoms that may include, fatigue, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight, according to the company statement.

The Swiss-based pharma company said in its statement that retailers, health care providers and wholesalers will be notified to stop distribution of the recalled products. IBSA warned patients to speak with their doctors before discontinuing use of the recalled medicine.

Advertisements

“Patients who are currently taking TIROSINT®-SOL should not discontinue use without contacting their healthcare provider for further guidance and/or replacement prescription,” the company spokesperson said in the statement.

“Any patients including those who might be pregnant, newborn infants, or elderly patients, should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product,” the pharmaceutical company added in the statement.

Affected lot numbers, product codes and expiration dates are listed on the FDA’s website. The recalled drug is a clear, colorless to slightly-yellow solution in a white 1 milliliter ampule.

“Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation [or] medications or removed by surgery,” WebMD stated on the website. “Having enough thyroid hormone is important for normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer).”

Scroll down to leave a comment and share your thoughts.

TRENDING TODAY

Photos Reveal Inside of Nashville Shooter Audrey Hale’s House
US

Photos Reveal Inside of Nashville Shooter Audrey Hale’s House

by RTM Staff
March 29, 2023
Police Chief Reveals Nashville Shooter Audrey Hale Had Another Target in Mind
US

Police Chief Reveals Nashville Shooter Audrey Hale Had Another Target in Mind

by RTM Staff
March 29, 2023


© 2023 Resist the Mainstream

Get Ad-Free Login Manage Account
No Result
View All Result
  • Newsletter
  • Store
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
  • About
  • Team
  • Contact
  • Editorial Standards
  • Core Values
  • Terms of Service
  • Privacy Policy
  • Affiliate Disclosure

© 2023 Resist the Mainstream